Azenta, Inc. (NASDAQ:AZTA) Shares Sold by Wealth Alliance

Wealth Alliance decreased its holdings in Azenta, Inc. (NASDAQ:AZTA) by 6.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,865 shares of the company’s stock after selling 255 shares during the quarter. Wealth Alliance’s holdings in Azenta were worth $203,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. Dimensional Fund Advisors LP boosted its stake in shares of Azenta by 16.5% during the second quarter. Dimensional Fund Advisors LP now owns 2,970,964 shares of the company’s stock worth $156,331,000 after buying an additional 421,719 shares during the period. Norges Bank acquired a new stake in Azenta during the 4th quarter worth approximately $140,856,000. Allspring Global Investments Holdings LLC grew its stake in shares of Azenta by 5.3% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,115,816 shares of the company’s stock valued at $58,714,000 after purchasing an additional 56,387 shares during the last quarter. Stephens Investment Management Group LLC increased its holdings in shares of Azenta by 1.7% in the fourth quarter. Stephens Investment Management Group LLC now owns 887,158 shares of the company’s stock valued at $57,789,000 after purchasing an additional 14,626 shares during the period. Finally, Schroder Investment Management Group raised its stake in shares of Azenta by 14.6% during the fourth quarter. Schroder Investment Management Group now owns 625,515 shares of the company’s stock worth $40,746,000 after purchasing an additional 79,913 shares during the last quarter. Institutional investors and hedge funds own 99.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the stock. Needham & Company LLC reissued a “buy” rating and issued a $69.00 price objective on shares of Azenta in a research note on Wednesday, August 7th. Evercore ISI raised their price objective on shares of Azenta from $52.00 to $53.00 and gave the company an “in-line” rating in a research report on Tuesday, July 2nd. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $67.00.

Azenta Stock Performance

Shares of NASDAQ AZTA opened at $49.27 on Friday. The company’s fifty day moving average is $52.45 and its two-hundred day moving average is $54.13. The firm has a market capitalization of $2.66 billion, a P/E ratio of -18.18 and a beta of 1.47. Azenta, Inc. has a one year low of $44.00 and a one year high of $69.16.

Azenta (NASDAQ:AZTA) last issued its earnings results on Tuesday, August 6th. The company reported $0.16 earnings per share for the quarter, topping the consensus estimate of $0.07 by $0.09. Azenta had a negative net margin of 23.66% and a positive return on equity of 0.89%. The company had revenue of $173.00 million for the quarter, compared to analyst estimates of $166.14 million. During the same period in the prior year, the business posted $0.13 earnings per share. The firm’s revenue for the quarter was up 4.2% compared to the same quarter last year. On average, sell-side analysts forecast that Azenta, Inc. will post 0.33 earnings per share for the current fiscal year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.